TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.0892
+0.0014 (1.59%)
Aug 21, 2026, 5:35 PM CET
TME Pharma Market Cap
TME Pharma has a market cap or net worth of €8.39 million as of August 21, 2026. Its market cap has decreased by -19.08% in one year.
Market Cap
8.39M
Enterprise Value
8.77M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.09
ChartMarket Cap Chart
Since September 30, 2016, TME Pharma's market cap has decreased from 43.13M to 8.39M, a decrease of -80.54%. That is a compound annual growth rate of -15.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 8.39M | 36.81% |
| Dec 31, 2025 | 6.13M | -13.10% |
| Dec 31, 2024 | 7.06M | 478.85% |
| Dec 29, 2023 | 1.22M | -26.24% |
| Dec 30, 2022 | 1.65M | -90.52% |
| Dec 31, 2021 | 17.44M | -28.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 26.92M |
| Advicenne | 25.49M |
| genOway Société anonyme | 22.68M |
| Aelis Farma | 14.41M |
| Aton | 12.59M |
| NFL Biosciences | 11.23M |
| Poxel | 10.49M |
| Biophytis | 9.62M |